Dr. Madoff on Selecting Patients With HCC Appropriate for Minimally Invasive Therapy

David C. Madoff, MD
Published: Monday, Mar 14, 2016



David C. Madoff, MD, professor of Radiology, vice chairman for Academic Affairs at Weill Cornell Medicine, discusses selecting patients with hepatocellular carcinoma (HCC) who are candidates for minimally invasive therapy.

Interventional oncologists work with multidisciplinary tumor boards in deciding a patient's treatment plan, Madoff explains, regarding surgery, radiation therapy, and medicine. Curative procedures are tailored for patients with cirrhosis and have small size tumors.

More palliative approaches are appropriate for patients with large tumor burden, where practitioners work to prolong survival and improve their quality of life.
SELECTED
LANGUAGE


David C. Madoff, MD, professor of Radiology, vice chairman for Academic Affairs at Weill Cornell Medicine, discusses selecting patients with hepatocellular carcinoma (HCC) who are candidates for minimally invasive therapy.

Interventional oncologists work with multidisciplinary tumor boards in deciding a patient's treatment plan, Madoff explains, regarding surgery, radiation therapy, and medicine. Curative procedures are tailored for patients with cirrhosis and have small size tumors.

More palliative approaches are appropriate for patients with large tumor burden, where practitioners work to prolong survival and improve their quality of life.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Rapid Reviews in Oncology®: Practice-Changing Data in Acute Myeloid Leukemia: A Rapid Update From Atlanta OnlineDec 21, 20182.0
Community Practice Connections™: 2nd Annual European Congress on Hematology™: Focus on Lymphoid MalignanciesDec 30, 20182.0
Publication Bottom Border
Border Publication
x